Comparison between whole-body magnetic resonance imaging and whole-body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma

被引:0
|
作者
Rodrigues, Monica Matos Correia [1 ]
Lederman, Henrique Manoel [2 ]
Grossman, Iona [2 ]
Castiglioni, Mario Luiz V. [3 ]
Marchetti, Renata [3 ]
Grass, Daphne Centola [2 ]
Luisi, Flavio Augusto Vercillo [1 ,4 ]
Caran, Eliana Maria Monteiro [1 ]
机构
[1] Univ Fed Sao Paulo, Paulista Sch Med, Support Grp Adolescents & Children Canc, Div Pediat Oncol,Inst Pediat Oncol, Sao Paulo, SP, Brazil
[2] Univ Fed Sao Paulo, Paulista Sch Med, Support Grp Adolescents & Children Canc IOP GRAACC, Div Radiol,Inst Pediat Oncol, Sao Paulo, SP, Brazil
[3] Fed Univ Sao Paulo UNIFESP, Imaging Diagnost Dept DDI, Nucl Med, HU, Sao Paulo, SP, Brazil
[4] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Support Grp Adolescents & Children Canc IOP GRAACC, Div Pediat Oncol,Inst Pediat Oncol, BR-04023062 Sao Paulo, SP, Brazil
关键词
MIBG; MRI; neoplasm staging; neuroblastoma; nuclear medicine; whole-body scintigraphy; DIFFUSION-WEIGHTED MRI; I-123-MIBG SCINTIGRAPHY; DIAGNOSTIC-VALUE; F-18-FDG PET; CHILDREN; DIFFERENTIATION; CT;
D O I
10.1002/pbc.30820
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundWhole-body metaiodobenzylguanidine (131I-MIBG) scintigraphy is the gold standard method to detect neuroblastoma; however, it depends on radioactive material and is expensive. In contrast, whole-body magnetic resonance imaging (WB-MRI) is affordable in developing countries and has been shown to be effective in the evaluation of solid tumors. This study aimed to compare the sensitivity and specificity of WB-MRI with MIBG in the detection of primary tumors and neuroblastoma metastases.ProcedureThis retrospective study enrolled patients with neuroblastoma between 2013 and 2020. All patients underwent WB-MRI and MIBG at intervals of up to 15 days. The results were marked in a table that discriminated anatomical regions for each patient. Two experts evaluated, independently and in anonymity, the WB-MRI images, and two others evaluated MIBG. The results were compared in terms of sensitivity and specificity, for each patient, considering MIBG as the gold standard. This study was approved by the UNIFESP Ethics Committee.ResultsThirty patients with neuroblastoma were enrolled in this study. The age ranged from 1 to 15 years, with a mean of 5.7 years. The interval between exams (WB-MRI and MIBG) ranged from 1 to 13 days, with an average of 6.67 days. Compared to MIBG, WB-MRI presented a sensitivity and specificity greater than or equal to 90% for the detection of primary neuroblastoma in bones and lymph nodes. When we consider the patient without individualizing the anatomical regions, WB-MRI presented sensitivity of 90% and specificity of 73.33%.ConclusionIn conclusion, WB-MRI is a sensitive and specific method to detect neuroblastoma in bone and lymph nodes and highly sensible to primary tumor diagnosis, suggesting that this test is a viable alternative in places where MIBG is difficult to access. Studies with a larger number of cases are necessary for definitive conclusions.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy
    Cascini, G.
    Falcone, C.
    Greco, C.
    Bertucci, B.
    Cipullo, S.
    Tamburrini, O.
    RADIOLOGIA MEDICA, 2008, 113 (08): : 1157 - 1170
  • [2] Whole-Body Magnetic Resonance Imaging: Assessment of Skeletal Metastases
    Moynagh, Michael R.
    Colleran, Gabrielle C.
    Tavernaraki, Katarina
    Eustace, Stephen J.
    Kavanagh, Eoin C.
    SEMINARS IN MUSCULOSKELETAL RADIOLOGY, 2010, 14 (01) : 22 - 36
  • [3] Whole-Body Magnetic Resonance Imaging in Rheumatology
    Chianca, Vito
    Lanckoronski, Micha
    Curti, Marco
    Chalian, Majid
    Sudol-Szopinska, Iwona
    Giraudo, Chiara
    Del Grande, Filippo
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2024, 62 (05) : 865 - 876
  • [4] Comparison of bone scintigraphy and whole-body diffusion-weighted magnetic resonance imaging in the detection of bone metastases
    Sozutok, Sinan
    Tarhan, Serdar
    Duzgun, Fatih
    Bilgin, Elvan S.
    CUKUROVA MEDICAL JOURNAL, 2021, 46 (01): : 132 - 140
  • [5] Comparison of whole-body magnetic resonance imaging and bone scintigraphy for detection of sceletal metastases in patients with solid tumors
    Wurm, K. F.
    Heinemann, U.
    Freund, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S133 - S133
  • [6] Whole-body MR imaging: Evaluation of patients for metastases
    Lauenstein, TC
    Goehde, SC
    Herborn, CU
    Goyen, M
    Oberhoff, C
    Debatin, JF
    Ruehm, SG
    Barkhausen, J
    RADIOLOGY, 2004, 233 (01) : 139 - 148
  • [7] Whole-body iodine-131 metaiodobenzylguanidine imaging for detection of bone metastases in patients with paraganglioma: comparison with bone scintigraphy
    Tetsuya Inoue
    Keiichiro Yoshinaga
    Koichi Morita
    Tohru Shiga
    Kakuko Kanegae
    Kenji Hirata
    Shozo Okamoto
    Nagara Tamaki
    Annals of Nuclear Medicine, 2007, 21 : 307 - 310
  • [8] Whole-body iodine-131 metaiodobenzylguanidine imaging for detection of bone metastases in patients with paraganglioma: comparison with bone scintigraphy
    Inoue, Tetsuya
    Yoshinaga, Keiichiro
    Morita, Koichi
    Shiga, Tohru
    Kanegae, Kakuko
    Hirata, Kenji
    Okamoto, Shozo
    Tamaki, Nagara
    ANNALS OF NUCLEAR MEDICINE, 2007, 21 (05) : 307 - 310
  • [9] Comparison of whole-body bone scintigraphy with axial skeleton magnetic resonance imaging in the skeletal evaluation of carcinoma prostate
    Venkatachalapathy, Vigneswara Srinivasan Sockkalingam
    Rajeshkannan, Ramiah
    Sarma, Manjit
    Pooleri, Ginil Kumar
    INDIAN JOURNAL OF UROLOGY, 2021, 37 (01) : 72 - 78
  • [10] Whole-Body Magnetic Resonance Imaging: Emerging Applications
    Colleran, Gabrielle C.
    Moynagh, Michael R.
    Tavernaraki, Katarina
    Shelly, Martin J.
    Eustace, Stephen J.
    Kavanagh, Eoin C.
    SEMINARS IN MUSCULOSKELETAL RADIOLOGY, 2010, 14 (01) : 57 - 67